§ 13F · FUND PROFILE
Omega Fund Management, LLC.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · — (13F)Positions · 10Turnover · — · Q1Filed · May 15, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
No new positions
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q1 2026
FILED MAY 15, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q1 |
|---|---|---|---|---|---|---|
| 1 | BCAX | Bicara Therapeutics Inc. | 2.39M | $48M | 29.2% | +9% |
| 2 | NUVB | Nuvation Bio Inc. | 8.08M | $35M | 21.2% | ±0% |
| 3 | BBOT | BridgeBio Oncology Therapeutics Inc. | 3.29M | $29M | 18.0% | ±0% |
| 4 | KMTS | Kestra Med Technologies Ltd | 1.02M | $20M | 12.5% | −26% |
| 5 | BBNX | Beta Bionics Inc. | 1.32M | $13M | 8.1% | ±0% |
| 6 | ENGN | enGene Holdings Inc. | 876K | $6M | 3.7% | ±0% |
| 7 | ALMS | Alumis Inc. | 241K | $5M | 3.3% | −63% |
| 8 | SANA | Sana Biotechnology, Inc. | 844K | $2M | 1.5% | ±0% |
| 9 | IMA | ImageneBio, Inc. | 455K | $2M | 1.4% | ±0% |
| 10 | REPL | Replimune Group | 249K | $2M | 1.2% | ±0% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE OMEGA SIGNAL
AC read
Omega Fund Management, LLC is classified as a Other fund.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q1 2026
Steady book
+0 buys · −0 exits · 0 changed
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed